Learn About Venous Thromboembolism (VTE)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Vermont Medical Center Inc
Mary Cushman is a Hematologist and an Oncologist in Burlington, Vermont. Dr. Cushman is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Embolectomy, and Hormone Replacement Therapy (HRT). Dr. Cushman is currently accepting new patients.
University Of Vermont Medical Center Inc
Neil Zakai is a Hematologist Oncology specialist and a Hematologist in Burlington, Vermont. Dr. Zakai is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Folate-Deficiency Anemia, Folate Deficiency, and Bone Marrow Aspiration. Dr. Zakai is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Samuel Goldhaber is a Cardiologist in Boston, Massachusetts. Dr. Goldhaber is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy. Dr. Goldhaber is currently accepting new patients.
Summary: This study is researching 2 different experimental drugs called REGN9933 and REGN7508 (called study drugs). The study is focused on adults undergoing a placement of a catheter in the vein, also called a 'PICC line'. The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related disease after catheter placement. The study is looking at se...
Summary: This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will...